Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA

GABA B receptor ligand-directed trimethyl chitosan/tripolyphosphate nanoparticles and their pMDI formulation for survivin siRNA pulmonary delivery

(2018) Suhui Ni et al.   CARBOHYDRATE POLYMERS

Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiency

(2016) Victoria Capel et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Chitosan nanoparticles for siRNA delivery: Optimizing formulation to increase stability and efficiency

(2014) H. Ragelle et al.   JOURNAL OF CONTROLLED RELEASE

Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts

(2012) SHAN CHEN et al.   ONCOLOGY REPORTS

Effect of PEGylation on the Toxicity and Permeability Enhancement of Chitosan

(2010) Luca Casettari et al.   BIOMACROMOLECULES

Polymer-related off-target effects in non-viral siRNA delivery

(2010) Olivia M. Merkel et al.   BIOMATERIALS

Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles

(2010) Ebbe J. B. Nielsen et al.   PHARMACEUTICAL RESEARCH

Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

(2009) E. Martinelli et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

pKaValues of Some Piperazines at (298, 303, 313, and 323) K

(2009) Farhad Khalili et al.   JOURNAL OF CHEMICAL AND ENGINEERING DATA